Overview
Artificial intelligence (AI) methods are being utilized to accelerate the initial stage of drug discovery and development. This initial stage involves identifying promising molecules from a large pool of possibilities. The overall drug development process is noted for its slow pace and high failure rate, as approximately 90% of drug candidates do not reach the market.
Research Context
Drug development is a process marked by significant challenges, including its slowness and a high propensity for failure. A considerable number of drug candidates, around 90%, do not progress to market availability. For a drug to be considered successful, it must meet several criteria: it needs to be safe, effective, capable of bypassing the body's natural defenses, and able to reach its intended target within the body.
Despite the acceleration of the initial molecule identification phase through AI, numerous challenges persist in the broader drug development pipeline. The complexities of ensuring a drug's safety, efficacy, and appropriate bodily distribution remain significant hurdles within this domain.
Findings
AI methods have accelerated the first step in drug discovery and development, which involves selecting promising molecules. This acceleration pertains specifically to the initial phase of identifying potential drug candidates from a vast array of options. The overall drug development process continues to be characterized by its slow nature and a high rate of failure, with about 90% of drug candidates failing to reach the market.
Why This Matters
The application of AI in the early stages of drug discovery addresses a critical bottleneck in a process known for its inefficiency and high rate of attrition. By accelerating the initial identification of promising molecules, AI offers a mechanism to potentially streamline the very beginning of a complex and often unsuccessful development pipeline. This is particularly relevant given that a significant majority of drug candidates do not ultimately become market-available drugs.